Arabic Arabic English English French French German German
dark

Adamas Announces Issuance of New Patents for GOCOVRI and ADS-4101

Adamas Pharmaceuticals, Inc. today announces the issuance of two patents covering GOCOVRI® (amantadine) extended-release capsules: U.S. Patent No. 11,065,213 issued on July 20, 2021, and U.S. Patent No. 11,077,073, projected to issue on August 3, 2021. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Acticor Biotech Announces the Completion of Enrollment in its GARDEN Clinical Trial, a COVID-19-induced Acute Respiratory Distress Syndrome Efficacy Study

Next Post

RedHill Biopharma Announces Settlement of Movantik® Patent Litigation with Apotex

Related Posts
Total
0
Share